These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 18395067)

  • 1. FDA set to tighten guidelines on industry dissemination of information on unapproved uses of medical products.
    Lang L
    Gastroenterology; 2008 Apr; 134(4):905. PubMed ID: 18395067
    [No Abstract]   [Full Text] [Related]  

  • 2. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Proposed rule.
    Fed Regist; 1998 Jun; 63(109):31143-61. PubMed ID: 10180130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA pilot programme in support of global harmonisation.
    Donawa ME
    Med Device Technol; 2003 Nov; 14(9):32-4. PubMed ID: 14682021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. US regulation of combination products.
    Donawa M
    Med Device Technol; 2009 Oct; 20(6):22, 24-5. PubMed ID: 20302139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(224):64556-88. PubMed ID: 10339052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U.S. medical device reporting: who is responsible?
    Donawa M
    Med Device Technol; 2005 Apr; 16(3):27-9. PubMed ID: 15871421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Draft guidance for industry; exports and imports under the FDA Export Reform and Enhancement Act of 1996--FDA. Notice.
    Fed Regist; 1998 Jun; 63(113):32219-34. PubMed ID: 10180275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, distributor reporting. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(17):4112-21. PubMed ID: 11010653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarification: 510k is premarket notification; it provides no patent or FDA approval.
    Burkhart CG
    J Drugs Dermatol; 2008 Feb; 7(2):105. PubMed ID: 18335644
    [No Abstract]   [Full Text] [Related]  

  • 12. The FDA defense: a prescription for easing the pain of punitive damage awards in medical products liability cases.
    Marthaler AL
    Spec Law Dig Health Care Law; 1997 Sep; (223):9-45. PubMed ID: 10173273
    [No Abstract]   [Full Text] [Related]  

  • 13. Off-label use of medical devices in radiology: regulatory standards and recent developments.
    Smith JJ
    J Am Coll Radiol; 2010; 7(2):115-9. PubMed ID: 20142085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondhand woes? The FDA takes a new look at refurbished devices; users consider the implications.
    Gwynne P
    Mater Manag Health Care; 1998 Sep; 7(9):22-4, 26. PubMed ID: 10185086
    [No Abstract]   [Full Text] [Related]  

  • 15. Complying with US nonconforming product requirements.
    Donawa M
    Med Device Technol; 2007; 18(3):22, 24-5. PubMed ID: 17585716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the Medical Device Directive.
    Donawa M
    Med Device Technol; 2003 Mar; 14(2):20-3. PubMed ID: 12698694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination products regulation at the FDA.
    Lauritsen KJ; Nguyen T
    Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications for Food and Drug Administration application approval to market a new drug; revision of postmarketing reporting requirements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Oct; 72(201):58993-9000. PubMed ID: 17966558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FDA, preemption, and the Supreme Court.
    Glantz LH; Annas GJ
    N Engl J Med; 2008 May; 358(18):1883-5. PubMed ID: 18450601
    [No Abstract]   [Full Text] [Related]  

  • 20. Import for export; reporting and recordkeeping requirements for unapproved or violative products imported for further processing or incorporation and subsequent export--FDA. Proposed rule.
    Fed Regist; 1998 Nov; 63(226):64930-7. PubMed ID: 10338872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.